These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Quinolinate and kainate neurotoxicity in neostriatal cultures is potentiated by co-culturing with neocortical neurons. Galarraga E, Surmeier DJ, Kitai ST. Brain Res; 1990 Apr 02; 512(2):269-76. PubMed ID: 1972342 [Abstract] [Full Text] [Related]
9. Hypothesis: a role for quinolinic acid in the neuropathology of glutaric aciduria type I. Heyes MP. Can J Neurol Sci; 1987 Aug 02; 14(3 Suppl):441-3. PubMed ID: 2960429 [Abstract] [Full Text] [Related]
10. Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Hansson O, Petersén A, Leist M, Nicotera P, Castilho RF, Brundin P. Proc Natl Acad Sci U S A; 1999 Jul 20; 96(15):8727-32. PubMed ID: 10411943 [Abstract] [Full Text] [Related]
11. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid. Harris CA, Miranda AF, Tanguay JJ, Boegman RJ, Beninger RJ, Jhamandas K. Br J Pharmacol; 1998 May 20; 124(2):391-9. PubMed ID: 9641558 [Abstract] [Full Text] [Related]
18. Quinolinic acid-induced increases in calbindin D28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's disease. Huang Q, Zhou D, Sapp E, Aizawa H, Ge P, Bird ED, Vonsattel JP, DiFiglia M. Neuroscience; 1995 Mar 20; 65(2):397-407. PubMed ID: 7777157 [Abstract] [Full Text] [Related]
19. The neurotoxic actions of quinolinic acid in the central nervous system. el-Defrawy SR, Boegman RJ, Jhamandas K, Beninger RJ. Can J Physiol Pharmacol; 1986 Mar 20; 64(3):369-75. PubMed ID: 2939936 [Abstract] [Full Text] [Related]